The estimated Net Worth of Namal Nawana is at least 838 千$ dollars as of 13 February 2018. Mr. Nawana owns over 6,600 units of Hologic stock worth over 556,390$ and over the last 7 years he sold HOLX stock worth over 0$. In addition, he makes 281,484$ as Independent Director at Hologic.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Nawana HOLX stock SEC Form 4 insiders trading
Namal has made over 1 trades of the Hologic stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 6,600 units of HOLX stock worth 250,008$ on 13 February 2018.
The largest trade he's ever made was buying 6,600 units of Hologic stock on 13 February 2018 worth over 250,008$. On average, Namal trades about 825 units every 0 days since 2018. As of 13 February 2018 he still owns at least 6,954 units of Hologic stock.
You can see the complete history of Mr. Nawana stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Namal Nawana biography
Namal Nawana serves as Independent Director of the Company. Mr. Nawana joined our Board in January 2018. Mr. Nawana most recently served as the Chief Executive Officer and a member of the Board of Directors of Smith & Nephew plc, from May 2018 to November 2019. Prior to joining Smith & Nephew, he was Chief Executive Officer, President and a member of the Board of Directors of Alere, Inc. from October 2014 until October 2017, when Alere was acquired by Abbott Laboratories. Mr. Nawana joined Alere as Chief Operating Officer in December 2012 before being named Interim Chief Executive Officer in July 2014. Before joining Alere, Mr. Nawana spent 15 years at Johnson & Johnson in various leadership roles. Most recently, he served as the Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company, from February 2011 to November 2012. Prior to that, Mr. Nawana served as Area Vice President for Johnson & Johnson Medical in Australia and New Zealand from January 2009 to February 2011, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia from 2007 to December 2008 and General Manager for DePuy Canada from 2004 to 2007. Mr. Nawana holds an Honors degree in Mechanical Engineering and a Master of Medical Science from the University of Adelaide, South Australia, and an MBA from Henley Management College.
What is the salary of Namal Nawana?
As the Independent Director of Hologic, the total compensation of Namal Nawana at Hologic is 281,484$. There are 13 executives at Hologic getting paid more, with Stephen MacMillan having the highest compensation of 12,374,800$.
How old is Namal Nawana?
Namal Nawana is 49, he's been the Independent Director of Hologic since 2018. There are 15 older and 3 younger executives at Hologic. The oldest executive at Hologic, Inc. is Dr. Jay A. Stein, 78, who is the Co-Founder, Chairman Emeritus, CTO & Sr. VP.
What's Namal Nawana's mailing address?
Namal's mailing address filed with the SEC is Campus Drive, Marlborough, Middlesex County, Massachusetts, 01752, United States.
Insiders trading at Hologic
Over the last 30 years, insiders at Hologic have traded over 311,276,394$ worth of Hologic stock and bought 385,967 units worth 8,452,795$ . The most active insiders traders include Carl Chigh River Limited Pa...、Carl C Icahn、Stephen P Macmillan. On average, Hologic executives and independent directors trade stock every 22 days with the average trade being worth of 3,042,940$. The most recent stock trade was executed by Karleen Marie Oberton on 29 August 2024, trading 52,679 units of HOLX stock currently worth 4,243,820$.
What does Hologic do?
driven by our ethos, the science of sure, we’re a diverse, dedicated, creative team that develops, markets and services some of the most innovative and accurate diagnostic imaging systems and surgical products on the planet. while we’re focused and passionate about our work, we never forget that what we’re really doing is giving people greater confidence and peace of mind in their diagnosis—enabling healthier lives, everywhere, every day. connect with us at hologic.com, on facebook at facebook.com/hologicjobs, and on twitter @hologic_jobs.
What does Hologic's logo look like?
Complete history of Mr. Nawana stock trades at Hologic
Hologic executives and stock owners
Hologic executives and other stock owners filed with the SEC include:
-
Stephen MacMillan,
Chairman of the Board, President, Chief Executive Officer -
Stephen P. MacMillan,
Chairman, CEO & Pres -
Kevin Thornal,
Division President, Diagnostics -
John Griffin,
General Counsel -
Peter Valenti,
Division President - Breast and Skeletal Health -
Karleen Oberton,
Chief Financial Officer -
Kevin R. Thornal,
Division Pres of Diagnostic Solutions -
John M. Griffin,
Gen. Counsel -
Sean S. Daugherty,
Group Pres of Breast/Skeletal Health & GYN Surgical Solutions -
Sally Crawford,
Lead Independent Director -
Ludwig Hantson,
Independent Director -
Charles Dockendorff,
Independent Director -
Scott Garrett,
Independent Director -
Namal Nawana,
Independent Director -
Amy Wendell,
Independent Director -
Christiana Stamoulis,
Independent Director -
Michael Watts,
Vice President - Investor Relations and Corporate Communications -
Allison Bebo,
Senior Vice President - Human Resources -
Mike Kelly,
Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs -
Paul Malenchini,
Chief Information Officer -
Elisabeth A. Hellmann,
Sr. VP of Global HR & Corp. Communications -
Ryan Simon,
VP of Investor Relations -
Monica Aguirre Berthelot,
Chief of Staff -
Sanjay Prabhakaran,
Regional Pres of Asia Pacific -
Jan Verstreken,
Group Pres of International -
Dr. Jay A. Stein,
Co-Founder, Chairman Emeritus, CTO & Sr. VP -
Elaine Ullian,
Director -
Nancy Leaming,
Director -
Thomas A. West,
Div President & GM, Diagnostic -
Christopher J Coughlin,
Director -
Eric B. Compton,
COO -
Robert W. Mc Mahon,
Chief Financial Officer -
Lawrence M Levy,
Director -
Carl Hull,
SVP and GM of Diagnostics -
Peter Soltani,
Vice President -
Benjamin Jordan Cohn,
Principal Accounting Officer -
Steven S. Williamson,
SVP, GYN Surgical -
John R Pekarsky,
Sr. VP, Sales -
Howard Jr Doran,
Vice President & BUD, ThinPrep -
Arthur G Lerner,
Director -
Laurie Fajardo,
Director -
Robert Cascella,
President & COO -
William A Peck,
Director -
Stuart A Kingsley,
President, Surgical Division -
Irwin Jacobs,
Director -
C William Mcdaniel,
Director -
Stetten Eric Von,
Vice President -
Daniel J Levangie,
Director -
Patrick J Sullivan,
Director -
Wayne Wilson,
Director -
Jay A Stein,
Director -
Samuel J. Merksamer,
Director -
Jonathan Christodoro,
Director -
David R Jr Lavance,
Director -
Claus Egstrand,
SVP and GM, International -
Carl Chigh River Limited Pa...,
-
Rohan Hastie,
Group VP & GM, Diagnostics -
Roger D. Mills,
SVP & GM, Service & Operations -
Robert H Lavallee,
Vice President -
Mark J Casey,
Senior V.P & General Counsel -
Carl C Icahn,
10% owner -
David Harding,
SVP, International -
David J Brady,
SVP, Human Resources -
Glenn P Muir,
Executive VP & CFO -
John W Cumming,
Chairman & CEO -
Sean S. Daugherty,
Group President, BSH & Surg. -
Jan Verstreken,
Group President, International -
Nanaz Mohtashami,
Director -
Brandon Schnittker,
Div. President, GYN Surgical -
Elisabeth A Hellmann,
SVP, Human Resources -
Erik S Anderson,
Div. Pres., Breast & Skeletal -
Essex D Mitchell,
Div. President, GYN Surgical -
Stacey D. Stewart,
Director -
Jennifer M Schneiders,
President, Diag. Solutions -
Peter Paul Dunne,
SVP, Human Resources